SEC Form 4 · accession 0001328255-17-000002
Syneos Health, Inc. · SYNH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory S Rush
Officer — Executive VP and CFO
Period of report
Jan 19, 2017
Accepted (ET)
Jan 23, 2017 · 6:44 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610950
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Jan 19, 2017 | F | 1,427 | $50.55 | D | 45,782 | D | |
| Class A Common Stock | Jan 20, 2017 | S | 1,573 | $50.50 | D | 44,209 | D | |
| Class A Common Stock | Jan 19, 2017 | M | 1,334 | $42.88 | A | 45,543 | D | |
| Class A Common Stock | Jan 19, 2017 | S | 1,334 | $50.65 | D | 44,209 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)F1,F2 | $42.88 | Jan 19, 2017 | M | 1,334 | D | — | Jan 19, 2026 | Class A Common Stock | 1,334 | 3,999 | D |
Explanation of responses
- F1The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 9, 2016.
- F2The shares subject to this option vest in four equal annual installments of 25% beginning on January 19, 2017, subject to continued employment.